Search Results for "Dcis And Nk Cells"
Original Source: Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With Hematologic Cancer and From Patients Who Do Not Have Cancer
RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors find better ways to treat the cancer. PURPOSE: This research study is looking at natural killer cells in bone marrow and blood samples from patients with hematologic cancer and from patients who do not have cancer.
Matching Channels
Stem cells can be found in all multicellular organisms and are characterized by the ability to renew themselves through mitotic cell division and differentiate into a diverse range of specialized ce...
Matching News
Oncotype DX® Predicts Recurrence in Patients with DCIS
The Oncotype DX® DCIS Score predicts the 10-year risk of local recurrence, defined as recurrence of DCIS or invasive breast cancer in the same breast, and can help guide radiation treatment decision-...
Using DCIS Score To Quantify Risk Of IBE For Breast Cancer Patients
The ductal carcinoma in situ (DCIS) Score quantifies the risk of ipsilateral breast event (IBE) and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a...
DCIS Score quantifies risk of IBE
(Journal of the National Cancer Institute) The ductal carcinoma in situ (DCIS) Score quantifies the risk of ipsilateral breast event (IBE) and invasive IBE risk, complements both traditional clinical...
DCIS Score quantifies risk of ipsilateral breast event
The ductal carcinoma in situ (DCIS) Score quantifies the risk of ipsilateral breast event (IBE) and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a...
Gamma imaging proves its prowess in DCIS detection
Breast-specific y camera scintigraphy is a highly specific tool for ductal carcinoma in situ (DCIS) detection, and provides 100 percent sensitivity when paired with mammography, according to a...
New study sheds new light on the progression and invasiveness of ductal breast cancer
(Elsevier Health Sciences) Ductal carcinoma in situ (DCIS), a precursor lesion for invasive breast cancer if untreated, is found in approximately 45% of patients with invasive ductal carcinoma (IDC)....
Study sheds new light on the progression and invasiveness of ductal breast cancer
Ductal carcinoma in situ (DCIS) is considered a precursor lesion for invasive breast cancer if untreated, and is found in approximately 45% of patients with invasive ductal carcinoma (IDC). Patients w...
Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer
The combined loss of two tumor suppressor genes, retinoblastoma (RB) and phosphatase and tensin homolog (PTEN) was shown to be strongly associated with progression of DCIS to invasive breast cancer, a...
Matching PubMed Articles
BACKGROUND: Breast ductal carcinoma in situ with microinvasion (DCIS-Mi) is considered to be the interim stage in the progression from DCIS to invasive breast cancer (IDC). Cases that exceed DCIS-Mi b...
OBJECTIVE: To assess knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS) and to explore the factors a...
Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive ductal carcinoma (IDC). Annotation of the genetic differences between the two lesions may assist in the identification of genes...
Mucocele-like lesions of the breast: a long-term follow-up study.
ABSTRACT: BACKGROUND: Mucocele-like lesions (MLL) of the breast were originally described as benign lesions composed of multiple cysts lined by uniform flat to cuboidal epithelium with extravasated mu...
Radiographic features for triple negative ductal carcinoma in situ of the breast.
BACKGROUND: Triple negative (TN) breast cancer is characterized as having a high malignancy potential and a poor prognosis. An understanding of the radiological features of TN DCIS will enable the ear...
